Quick answer: In eligible adults diagnosed with chronic migraine, onabotulinumtoxinA is one of the preventive treatment options aimed at reducing the number of headache days.
What is Botulinum Toxin Treatment in Chronic Migraine?
In eligible adults diagnosed with chronic migraine, onabotulinumtoxinA is one of the preventive treatment options aimed at reducing the number of headache days. The goal of botulinum toxin applications is to temporarily and in a controlled manner modulate target muscle or gland activity. The outcome varies according to individual anatomy, muscle strength, application area, and clinical objective.
Why is chronic migraine evaluated separately?
Chronic migraine does not simply mean frequent headaches. The frequency of headache days, migraine characteristics, acute medication use, accompanying sleep and mood disorders, and previously used preventive treatments are evaluated together. A headache diary is valuable in monitoring diagnosis and treatment response.
What is the purpose of botulinum toxin?
The goal is not to abort the acute attack at that moment, but to be part of a preventive treatment plan aimed at reducing the future headache burden in eligible chronic migraine patients. Response is evaluated not only by pain severity, but through the number of headache days, acute medication need, and daily function.
Relationship with other treatments
A procedural approach alone is not sufficient without reviewing sleep, triggers, acute medication overuse, and other preventive treatments. The treatment plan is established holistically according to the individual’s prior responses and comorbid conditions.
Who can be evaluated for this?
A distinction is made between episodic migraine and chronic migraine; headache diary, medication overuse, and other preventive treatments are evaluated.
Pre-procedure evaluation
Rather than applying a standard point template, our approach in our clinic is to evaluate medical history, dynamic examination, facial or functional anatomy, asymmetry, previous applications, and the individual’s goals together. In the evaluation, the person’s medical history, anatomical features, prior applications, and expectations from treatment are addressed together.
Scientific evidence
The use of botulinum toxin in this field is addressed within the framework of clinical research and expert assessments. Appropriate patient selection, accurately defined goals, and personalized evaluation are the foundation of treatment.
When does the effect begin and how long does it last?
The effect usually begins to appear within the first few days and becomes more pronounced in subsequent days. The duration can vary according to the application area, muscle activity, and individual biological differences. The timing of the follow-up examination is scheduled according to the type of application.
Possible side effects
Pain, tenderness, bruising, or headache may be seen at the injection site. Area-specific effects such as temporary asymmetry, unwanted weakness in adjacent muscles, changes in eyelid/eyebrow position, changes in oral functions, or difficulty swallowing may occur. Rare but serious generalized muscle weakness, swallowing difficulty, or breathing difficulty requires emergency medical evaluation.
Who might it not be suitable for?
Active infection at the application site, known hypersensitivity to botulinum toxin components, and certain neuromuscular diseases require special attention. Pregnancy/breastfeeding, anticoagulant use, aminoglycosides or medications that can affect neuromuscular transmission, and previous botulinum toxin applications must be shared with the physician.
Post-procedure considerations
There may be temporary tenderness, small bruises, or short-term head and neck discomfort at the injection sites. The preventive effect of the treatment is not evaluated on the same day; maintaining a headache diary and evaluating the change together at the planned follow-up time is beneficial. Contact our clinic if unusual generalized weakness, marked difficulty swallowing, new visual complaints, or unexpected neurological symptoms develop; emergency evaluation is required for breathing or severe swallowing difficulties.
Relationship with pain treatment
Chronic migraine is a specific neurological condition of recurring headaches, and its evaluation requires a headache-specific diagnosis and follow-up along with a general pain approach. You can review the Pain and Algology Guides page for our clinic’s multidimensional pain approach.
Our approach at our Bodrum clinic
In therapeutic applications, we do not evaluate botulinum toxin solely as an “injection procedure,” but in coordination with diagnosis, functional goals, rehabilitation, and, when necessary, relevant specialties.
Frequently asked questions
Is the effect permanent?
No. Neuromuscular or neuroglandular transmission re-establishes over time, and the effect diminishes.
Is the procedure planned the same way for everyone?
No. The plan is individualized by taking into account clinical findings, anatomy, functional goals, and previous application experiences.
Why is the follow-up evaluation important?
The effect develops gradually. The follow-up evaluation helps review the clinical response, function, and treatment goals together.
References
Peer-reviewed botulinum toxin research, systematic reviews, expert consensuses, and relevant clinical guidelines have been taken as the basis.
This page is for general informational purposes; it does not replace personalized diagnosis or treatment advice.
